TRENDS

• Authorized Generics Solidifying Their Presence in Japan Gx Market
  June 16, 2017

• Japan Pharma Earnings Show SGLT-2 Market Uptake Still Slow
  May 22, 2017

• Astellas’ LLP Sale to Private Equity Group Signals New Business Model for Older Drugs
  April 10, 2017

• Mitsubishi Tanabe’s Exit Shows Research-Driven Makers’ Generic Biz at Crossroads
  March 31, 2017

• As Takeda’s R&D Rejig Progresses, Biotech JV Launch Sets Direction for Its Japan Regime
  March 23, 2017

• Daiichi Sankyo Espha Goes on AG Spree as It Wins Nod for 7 Major Brands
  February 16, 2017

• Montelukast AG Achieves Rapid Market Penetration, Enjoys Stronger Start than Candesartan AG
  February 7, 2017

• AGs Set to Break into 10 Billion Yen Territory in Japan
  November 14, 2016

• Gilead Stays Pat on Hep C Plan, Japan Chief Says Innovation Outstrips Re-Pricing Hit
  October 18, 2016

• Japan’s Established Drug Market Shines as Renewed Opportunity for Foreign Generic Firms
  September 26, 2016

• Sumitomo Dainippon Feeling Sense of Crisis about Operating Profit to Approach Zero; Will Offer Early Retirement and Cut Executive Compensation
  September 15, 2016

• Surprise Rule Change Pops Up Yet Again, This Time with Taltz
  September 5, 2016

• Top Global Pharmas Lackluster in Japan while Hep C Drug Makers Flourish
  June 21, 2016

• Success of Daiichi Sankyo’s New Midterm Plan to Hinge on Edoxaban; 120 Billion Yen Sales Target Set for FY2020
  April 13, 2016

• Multiple Authorized Generics Get Approval towards June Listing as Pharmas See Opportunities
  February 17, 2016

• Japan Drug Makers Foresee 6% Sales Growth in FY2015: Jiho Tally
  February 15, 2016

• 17,800 Hep C Patients Prescribed Sovaldi in 6 Months; Clinical Benefits Out of Consideration in New Re-Pricing Rule
  January 27, 2016

• Global Pharmas Mull Excluding Japan from In-Licensing Deals on Annual Revision Fears, Softer Yen
  January 26, 2016

• Takeda’s Exit from Diabetes Research a Symbolic Move under Weber Leadership
  January 20, 2016

• Teva JV Deal Marks Turning Point in Takeda’s Japanese Business
  January 6, 2016

ページ